US Patent Issued to HANMI PHARM. on March 1 for "Glucagon derivative and a composition comprising a long acting conjugate of the same" (South Korean Inventors)

Press/Media: Press / Media

Period2022 Mar 2

Media coverage

1

Media coverage

  • TitleUS Patent Issued to HANMI PHARM. on March 1 for "Glucagon derivative and a composition comprising a long acting conjugate of the same" (South Korean Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date22/3/2
    Personsjin woo Park